These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2254723)

  • 21. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk factors for the development of diabetic retinopathy in patients with insulin-dependent diabetes mellitus treated with continuous subcutaneous insulin infusion].
    Austenat E
    Wien Med Wochenschr; 1992; 142(13):277-80. PubMed ID: 1413821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control.
    Hatz K; Minder AE; Lehmann R; Drescher T; Gerendas B; Schmidt-Erfurth U; Kaider A; Pruente C; Zulewski H
    Diabetes Res Clin Pract; 2019 Feb; 148():234-239. PubMed ID: 30684505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.
    Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Di Vincenzo A; Modarelli F; Ciofetta M; Lepore M; Annibale B; Torlone E
    Diabetologia; 1994 Dec; 37(12):1265-76. PubMed ID: 7895957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of proliferative retinopathy in patients with long-standing insulin-dependent diabetes mellitus.
    Styles CJ; Dodds W; Watkins P; McHugh D; Blach R
    Eye (Lond); 2000 Dec; 14(Pt 6):851-4. PubMed ID: 11584841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia.
    Pampanelli S; Fanelli C; Lalli C; Ciofetta M; Sindaco PD; Lepore M; Modarelli F; Rambotti AM; Epifano L; Di Vincenzo A; Bartocci L; Annibale B; Brunetti P; Bolli GB
    Diabetologia; 1996 Jun; 39(6):677-86. PubMed ID: 8781763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].
    Dorchy H
    Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
    Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
    Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus.
    Persson B; Swahn ML; Hjertberg R; Hanson U; Nord E; Nordlander E; Hansson LO
    Diabetes Res Clin Pract; 2002 Nov; 58(2):115-21. PubMed ID: 12213353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
    Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Aiello LP;
    Diabetes Care; 2014; 37(1):17-23. PubMed ID: 24356593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
    White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
    Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic retinopathy after two years of intensified insulin treatment. Follow-up of the Kroc Collaborative Study. The Kroc Collaborative Study Group.
    JAMA; 1988 Jul; 260(1):37-41. PubMed ID: 2898025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 36 months continuous subcutaneous insulin infusion (CSII) in insulin dependent diabetes (IDDM)--influence on early stages of retinopathy, nephropathy and neuropathy--psychological analysis.
    Bibergeil H; Hüttl I; Felsing W; Felsing U; Seidlein I; Herfurth S; Dabels J; Reichel G; Lüder C; Albrecht G
    Exp Clin Endocrinol; 1987 Aug; 90(1):51-61. PubMed ID: 3666060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
    Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
    Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group.
    Diabetes Care; 1987; 10(1):1-19. PubMed ID: 2882967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.